US Pharma Firm Chooses OmniComm’s TrialMaster For Phase III Study On CNS Disorders
The contract is for in excess of $200,000 and total revenue generated from this customer exceeds $750,000 over the last six months. Stephen Johnson, COO of OmniComm Systems,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.